Home › Heart Diseases › NCT06587204
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * History of pre-diabetes/diabetes and/or pre-hypertension/hypertension * History of Cardiometabolic risk factors including the following: hypertension, Coronary Artery Disease (CAD), heart attack, heart failure, stroke, atherosclerosis, arrhythmias, Peripheral Artery Disease (PAD), type 2 diabetes, metabolic syndrome, obesity, dyslipidemia, insulin resistance, or elevated cholesterol. * Identify as Black or non-White Hispanic * Own a smart phone Exclusion Criteria: * Does not meet inclusion criteria
About the study
The objective of the UDECIDE study is to demonstrate adherence to decentralized clinical trials among underrepresented groups with cardiometabolic conditions .
What is being tested
- Control Group (other)
- Decentralized Group (behavioral)
- Digital Literacy Navigation Group (behavioral)
- Social Care Navigation Group (behavioral)
Sponsor: University of Miami · Participants: 125 · Started: Sep 15, 2025
Contact the study team
- Carolina Scaramutti, PhD · Phone: 305-243-1298
Official record on ClinicalTrials.gov — NCT06587204
Locations in the U.S.
| Florida | University of Miami, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.